Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6849)
All Articles published online
|
Publishing Process of This Article
|
May 14, 2021 (publication date) through Apr 19, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | El-Salhy M, Casen C, Valeur J, Hausken T, Hatlebakk JG. Responses to faecal microbiota transplantation in female and male patients with irritable bowel syndrome. World J Gastroenterol 2021; 27(18): 2219-2237 [PMID: 34025075 DOI: 10.3748/wjg.v27.i18.2219] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v27/i18/2219.htm |
| Number | Citing Articles |
| 1 |
Anastasia Andreevna Volodikhina, Aminat Rabadanovna Akhmedova, Marat Borisovich Uzdenov, Milana Lemayevna Dzhabrailova, Rassita Khizirovna Voytleva, Vladislav Ikromzhonovich Achilov. Possibilities of Correction of Functional Disorders of the Gastrointestinal Tract in Patients with Anxiety Disorders. Pharmacophore 2022; 13(3): 98 doi: 10.51847/lRJ9ReA6Ft
|
| 2 |
Magdy El-Salhy, Renate Winkel, Christina Casen, Trygve Hausken, Odd Helge Gilja, Jan Gunnar Hatlebakk. Efficacy of Fecal Microbiota Transplantation for Patients With Irritable Bowel Syndrome at 3 Years After Transplantation. Gastroenterology 2022; 163(4): 982 doi: 10.1053/j.gastro.2022.06.020
|
| 3 |
Manuele Biazzo, Gabriele Deidda. Fecal Microbiota Transplantation as New Therapeutic Avenue for Human Diseases. Journal of Clinical Medicine 2022; 11(14): 4119 doi: 10.3390/jcm11144119
|
| 4 |
Amal Mohamed Elhusein, Hammad Ali Fadlalmola. Efficacy of Fecal Microbiota Transplantation in Irritable Bowel Syndrome Patients. Gastroenterology Nursing 2022; 45(1): 11 doi: 10.1097/SGA.0000000000000652
|
| 5 |
Alfonso Benítez-Páez, Annick V. Hartstra, Max Nieuwdorp, Yolanda Sanz.
Species- and strain-level assessment using
rrn
long-amplicons suggests donor’s influence on gut microbial transference via fecal transplants in metabolic syndrome subjects
. Gut Microbes 2022; 14(1) doi: 10.1080/19490976.2022.2078621
|
| 6 |
Gabriela Piovezani Ramos, Michael Camilleri. Current and Future Therapeutic Options for Irritable Bowel Syndrome with Diarrhea and Functional Diarrhea. Digestive Diseases and Sciences 2023; 68(5): 1677 doi: 10.1007/s10620-022-07700-8
|
| 7 |
Xiaoqiang Zhu, Lijun Zhao, Liang Lei, Yanhong Zhu, Jun Xu, Li Liu. Fecal microbiota transplantation ameliorates abdominal obesity through inhibiting microbiota-mediated intestinal barrier damage and inflammation in mice. Microbiological Research 2024; 282: 127654 doi: 10.1016/j.micres.2024.127654
|
| 8 |
Lu Hang, Yan Zhou, Yang-Yang Meng, Ya Feng, Yin-Shu Wang, Jian-Ye Yuan. Progress in understanding of relationship between short chain fatty acids and irritable bowel syndrome. World Chinese Journal of Digestology 2021; 29(19): 1102 doi: 10.11569/wcjd.v29.i19.1102
|
| 9 |
Motonobu Hamazaki, Tsunaki Sawada, Takeshi Yamamura, Keiko Maeda, Yasuyuki Mizutani, Eri Ishikawa, Satoshi Furune, Kenta Yamamoto, Takuya Ishikawa, Naomi Kakushima, Kazuhiro Furukawa, Eizaburo Ohno, Takashi Honda, Hiroki Kawashima, Masatoshi Ishigami, Masanao Nakamura, Mitsuhiro Fujishiro. Fecal microbiota transplantation in the treatment of irritable bowel syndrome: a single-center prospective study in Japan. BMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02408-5
|
| 10 |
Lina He, Rongping Chen, Bangzhou Zhang, Shuo Zhang, Barkat Ali Khan, Dan Zhu, Zezhen Wu, Chuanxing Xiao, Baolong Chen, Fengwu Chen, Kaijian Hou. Fecal microbiota transplantation treatment of autoimmune-mediated type 1 diabetes mellitus. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.930872
|
| 11 |
Maria Napolitano, Ernesto Fasulo, Federica Ungaro, Luca Massimino, Emanuele Sinagra, Silvio Danese, Francesco Vito Mandarino. Gut Dysbiosis in Irritable Bowel Syndrome: A Narrative Review on Correlation with Disease Subtypes and Novel Therapeutic Implications. Microorganisms 2023; 11(10): 2369 doi: 10.3390/microorganisms11102369
|
| 12 |
Magdy El‐Salhy, Tarek Mazzawi, Trygve Hausken, Jan Gunnar Hatlebakk. Irritable bowel syndrome patients who are not likely to respond to fecal microbiota transplantation. Neurogastroenterology & Motility 2022; 34(9) doi: 10.1111/nmo.14353
|
| 13 |
Mancai Wang, Xiaofeng Xie, Songbo Zhao, Xiaojuan Ma, Zheyuan Wang, Youcheng Zhang. Fecal microbiota transplantation for irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1136343
|
| 14 |
Magdy El-Salhy, Tanisa Patcharatrakul, Sutep Gonlachanvit. Fecal microbiota transplantation for irritable bowel syndrome: An intervention for the 21<sup>st</sup> century. World Journal of Gastroenterology 2021; 27(22): 2921-2943 doi: 10.3748/wjg.v27.i22.2921
|
| 15 |
Theodore Rokkas, Georgina L. Hold. A systematic review, pairwise meta-analysis and network meta-analysis of randomized controlled trials exploring the role of fecal microbiota transplantation in irritable bowel syndrome. European Journal of Gastroenterology & Hepatology 2023; 35(4): 471 doi: 10.1097/MEG.0000000000002519
|
| 16 |
Magdy El-Salhy, Odd Helge Gilja, Jan Gunnar Hatlebakk. Increasing the transplant dose and repeating faecal microbiota transplantation results in the responses of male patients with IBS reaching those of females. Scandinavian Journal of Gastroenterology 2024; 59(4): 391 doi: 10.1080/00365521.2023.2292479
|
| 17 |
Claudia Di Rosa, Annamaria Altomare, Vittoria Terrigno, Florencia Carbone, Jan Tack, Michele Cicala, Michele Guarino. Constipation-Predominant Irritable Bowel Syndrome (IBS-C): Effects of Different Nutritional Patterns on Intestinal Dysbiosis and Symptoms. Nutrients 2023; 15(7): 1647 doi: 10.3390/nu15071647
|
| 18 |
Liping Liu, Qin Wu, Yuping Chen, Huiling Ren, Qi Zhang, Hengyue Yang, Wenying Zhang, Tingyu Ding, Shujie Wang, Yan Zhang, Yun Liu, Jihu Sun. Gut microbiota in chronic pain: Novel insights into mechanisms and promising therapeutic strategies. International Immunopharmacology 2023; 115: 109685 doi: 10.1016/j.intimp.2023.109685
|
| 19 |
Magdy El‐Salhy, Odd Helge Gilja, Jan Gunnar Hatlebakk. Letter: A step forward towards a standard FMT protocol for IBS. Alimentary Pharmacology & Therapeutics 2023; 58(10): 1115 doi: 10.1111/apt.17749
|
| 20 |
Frances Widjaja, Ivonne M. C. M. Rietjens. From-Toilet-to-Freezer: A Review on Requirements for an Automatic Protocol to Collect and Store Human Fecal Samples for Research Purposes. Biomedicines 2023; 11(10): 2658 doi: 10.3390/biomedicines11102658
|
| 21 |
Jiafei Liu, Liqiang Gu, Mingqing Zhang, Shiwu Zhang, Min Wang, Yu Long, Xipeng Zhang. The Fecal Microbiota Transplantation: A Remarkable Clinical Therapy for Slow Transit Constipation in Future. Frontiers in Cellular and Infection Microbiology 2021; 11 doi: 10.3389/fcimb.2021.732474
|